RecruitingNCT06046079

Predictors of Health Service Utilizations Among Key Population in Washington DC

A Mixed Methods Study of the Association Between LAI PrEP Initiation and Adherence, and Utilization of Health and Social Support Services Among Key Populations in Washington DC

Sponsor

Us Helping Us, People Into Living, Inc.

Enrollment

100 participants

Start Date

Aug 25, 2023

Study Type

OBSERVATIONAL

Conditions

Health Behavior HIV Pre-exposure Prophylaxis

Summary

The primary objective of the proposed study is to investigate how PrEP use might result in an increase in the utilization of health and social services offered at a local community-based organization. Our primary hypothesis is that the investigators will observe higher utilization of sexual health (STI screenings), psychosocial health (psychotherapy, and substance use treatment) and other social services (emergency cash assistance, food pantry, transportation assistance, clothing,and housing resources) among PrEP users (LAI-PrEP or daily oral) compared to participants who are PrEP naïve over the 12-month follow-up period.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at what factors predict how often people who are HIV-negative but at risk use health services, particularly those related to PrEP (a daily pill or injection that prevents HIV). The goal is to understand barriers and improve access to HIV prevention for at-risk communities in Washington DC. **You may be eligible if...** - You are 18 or older - You are confirmed HIV-negative - You live in the Washington DC metropolitan area - You are either currently taking daily oral PrEP, on long-acting injectable PrEP, or have never used PrEP **You may NOT be eligible if...** - You are under 18 - You live outside the Washington DC metro area - You cannot read or speak English - You are currently HIV-positive Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.